Topical treatment for psoriasis targets deeper layers of the skin, improves healing

A novel combination anti-psoriasis therapy has potential for superior and longer-lasting therapeutic effects than current topical treatments by targeting genetic abnormalities in deeper layers of the skin. This research is being presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.

Psoriasis is a chronic autoimmune skin disorder that significantly impacts a patient's quality of life. The overactive immune system triggers to grow rapidly and then form psoriatic plaques. Approximately 7.5 million people have psoriasis in the United States, according to the American Academy of Dermatology.

Mandip Sachdeva, Ph.D., and Srujan Marepally, Ph.D., along with their colleagues from Florida Agricultural and Mechanical University, developed a topical formulation of a gene-regulating nanoparticle (Dual-F-NALP) carrying two nucleic acids, which controls the cells from developing psoriatic plaques and suppresses inflammation.

To test the effectiveness of their formulation they used the Psoriasis Area and Severity Index (PASI), a clinical scoring system from 0


Explore further

Many psoriasis patients going without treatment, study finds

Citation: Topical treatment for psoriasis targets deeper layers of the skin, improves healing (2013, November 14) retrieved 15 June 2019 from https://medicalxpress.com/news/2013-11-topical-treatment-psoriasis-deeper-layers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more